Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.

@article{Chang2016ClinicalSO,
  title={Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.},
  author={Ming-Chu Chang and Yu-ting Chang and Jia-Yang Chen and Yung-Ming Jeng and Ching-Yao Yang and Yu-Wen Tien and Shih-Hung Yang and Huai-Lu Chen and Ting-Yuan Liang and Chien-Fang Wang and Eva Y.-H.P. Lee and Ying-Chih Chang and Wen-Hwa Lee},
  journal={Clinical chemistry},
  year={2016},
  volume={62 3},
  pages={
          505-13
        }
}
BACKGROUND Characterization of circulating tumor cells (CTCs) has been used to provide prognostic, predictive, and pharmacodynamic information in many different cancers. However, the clinical significance of CTCs and circulating tumor microemboli (CTM) in patients with pancreatic ductal adenocarcinoma (PDAC) has yet to be determined. METHODS In this prospective study, CTCs and CTM were enumerated in the peripheral blood of 63 patients with PDAC before treatment using anti-EpCAM (epithelial… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Circulating tumor

N Aceto, A Bardia, DT Miyamoto, MC Donaldson, JA Spencer
  • cell
  • 2014

European cancer mortality predictions for the year 2014.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2014
VIEW 2 EXCERPTS

clusters are oligoclonal precursors of breast cancer metastasis

E Soeth, U Grigoleit, +3 authors B Kremer
  • 2014